Rockwell Medical
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 237
- Market Cap
- $95.2M
- Website
- http://www.rockwellmed.com
- Introduction
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT05110768
Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04689932
- Locations
- 🇺🇸
Luxury Dialysis, Webster, Texas, United States
Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT04409132
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT04239391
- Locations
- 🇺🇸
Children's Mercy Hospital, Kansas City, Missouri, United States
🇺🇸Loma Linda University Hospital, Loma Linda, California, United States
🇺🇸Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States
A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04042324
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT03303144
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis
- Conditions
- Interventions
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2019-08-08
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02909153
Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
- Conditions
- Interventions
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT02905981
Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2016-05-10
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT02767128
- Locations
- 🇺🇸
Jasper Clinic, Kalamazoo, Michigan, United States
Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
- First Posted Date
- 2016-04-14
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02739100
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States